1-4 of 4
Sarah Worth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Outcomes of Stem Cell Transplant in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents: Experience from Routine Clinical Practices in the United States

Free
Kimo Bachiashvili, Esprit Ma, Achal Patel, Rongrong Wang, Archibong Yellow-Duke, Melissa Montez, Cat N. Bui, Sarah Worth, Pankit Vachhani
Journal: Blood
Blood (2023) 142 (Supplement 1): 7415.
https://doi.org/10.1182/blood-2023-178008
Published: 2023
Journal Articles

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Free
Kendall Diebold, Sarah Worth, Kimo Bachiashvili, Pankit Vachhani, Sravanti Rangaraju, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 5910.
https://doi.org/10.1182/blood-2023-185198
Published: 2023
Journal Articles

Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US

Free
Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Wei-Han Cheng, Michael Werner, Jonathan Abbas, William Donnellan
Journal: Blood
Blood (2022) 140 (Supplement 1): 683–684.
https://doi.org/10.1182/blood-2022-157509
Published: 2022
Journal Articles

Hypomethylating Agent/Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia

Free
Omer Hassan Jamy, Sarah Worth, Sravanti Rangaraju, Kimo Bachiashvili, Pankit Vachhani, Ravi Bhatia
Journal: Blood
Blood (2021) 138 (Supplement 1): 2322.
https://doi.org/10.1182/blood-2021-149778
Published: 2021